Abiopharma

News list

Newcomb Matthew S 🔴 sold 65.0K shares of Chime Financial, Inc. (CHYM) at $31.00 ($2.0M) Transaction Date: Aug 06, 2026 | Filing ID: 000011

Full text

News bot Aug. 10, 2026, 11:34 p.m.
🔍 Newcomb Matthew S (Executive)

Company: Chime Financial, Inc. (CHYM)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 65,000
- Total shares held: 478,172
Detailed Transactions and Holdings:
- Sold 20,000 shares of Class A Common Stock at $28.3 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,261,070.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
- Sold 45,000 shares of Class A Common Stock at $31.0 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,216,070.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: H | shares_owned_after: 478,172.00
Footnotes:
- F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2025.
- F2: Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F3: These shares are held by 2019 Newcomb Fox Family Trust, for which the Reporting Person and his spouse serve as trustees.